Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Volume Contribution (% pts cc): 15.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
15.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
14.0% in FY2024
History
6 years
Since FY2018
Sources
6
Documents cited below
Where the FY2025 figure comes from
“Net sales were USD 54.5 billion (+8%, +8% cc), with volume contributing 15 percentage points to growth. Generic competition had a negative impact of 6 percentage points, pricing had a negative impact of 1 percentage point and currency had no impact.”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K (Operating Review).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Volume Contribution (% pts cc) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.0% | +1.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 14.0% | -2.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 16.0% | +5.0 pts | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2022 | Dec 31, 2022 | 11.0% | – | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2019 | Dec 31, 2019 | 12.0% | +3.0 pts | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2018 | Dec 31, 2018 | 9.0% | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Volume Contribution (% pts cc) (%), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bridge-volume-pp
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.